Processa Pharmaceuticals's total assets for Q2 2025 were $8.18M, an increase of 70.11% from the previous quarter. PCSA total liabilities were $2.07M for the fiscal quarter, a 61.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.